Immune escape mechanisms of intraocular tumors

Abi-Hanna, 1988, HLA antigens in ocular tissues. I. In vivo expression in human eyes, Transplantation, 45, 610, 10.1097/00007890-198803000-00021 Agata, 1996, Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes, Int. Immunol., 8, 765, 10.1093/intimm/8.5.765 Albert, 1997, The ocular melanoma story. LIII Edward Jackson Memorial Lecture: Part II, Am. J. Ophthalmol., 123, 729, 10.1016/S0002-9394(14)71119-5 Alexander, 2002, Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes, Diabetes, 51, 356, 10.2337/diabetes.51.2.356 Algarra, 2000, The HLA crossroad in tumor immunology, Hum. Immunol., 61, 65, 10.1016/S0198-8859(99)00156-1 Alizadeh, 2003, Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer, Invest. Ophthalmol. Vis. Sci., 44, 3042, 10.1167/iovs.02-1147 Anand, 1994, Characterization of intraocular tumors arising in transgenic mice, Invest. Ophthalmol. Vis. Sci., 35, 3533 Anastassiou, 2001, Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value, J. Pathol., 194, 466, 10.1002/path.926 Apte, 1997, Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors, Invest. Ophthalmol. Vis. Sci., 38, 1277 Apte, 1996, Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye, J. Immunol., 156, 2667, 10.4049/jimmunol.156.8.2667 Apte, 1998, Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege, J. Immunol., 160, 5693, 10.4049/jimmunol.160.12.5693 Ashton, 1964, Primary tumors of the iris, Br. J. Ophthalmol., 48, 650, 10.1136/bjo.48.12.650 Astigiano, 2005, Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer, Neoplasia, 7, 390, 10.1593/neo.04658 Augsburger, 1993, Planned combined I-125 plaque irradiation and indirect ophthalmoscope laser therapy for choroidal malignant melanoma, Ophthal. Surg., 24, 76 Balkwill, 2005, Smoldering and polarized inflammation in the initiation and promotion of malignant disease, Cancer Cell, 7, 211, 10.1016/j.ccr.2005.02.013 Balkwill, 2001, Inflammation and cancer: back to virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0 Baniyash, 2004, TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response, Nat. Rev. Immunol., 4, 675, 10.1038/nri1434 Beatty, 2000, IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen, J. Immunol., 165, 5502, 10.4049/jimmunol.165.10.5502 Beutelspacher, 2006, Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression, Eur. J. Immunol., 36, 690, 10.1002/eji.200535238 Bill, 1970, Ocular circulation, 278 Billingham, 1953, Studies on the problem of corneal homografts, Proc. R. Soc. Lond. B Biol. Sci., 141, 392, 10.1098/rspb.1953.0049 Billingham, 1951, Effect of cortisone on survival of skin homografts in rabbits, Br. Med. J., 1, 1157, 10.1136/bmj.1.4716.1157 Birkeland, 1995, Cancer risk after renal transplantation in the Nordic countries, 1964–1986, Int. J. Cancer, 60, 183, 10.1002/ijc.2910600209 Blank, 2004, PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8 + T cells, Cancer Res., 64, 1140, 10.1158/0008-5472.CAN-03-3259 Blom, 1997, Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells, J. Interferon Cytokine Res., 17, 695, 10.1089/jir.1997.17.695 Blom, 1997, Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma, Invest. Ophthalmol. Vis. Sci., 38, 1865 Blom, 1997, Inverse correlation between expression of HLA-B and c-myc in uveal melanoma, J. Pathol., 181, 75, 10.1002/(SICI)1096-9896(199701)181:1<75::AID-PATH724>3.0.CO;2-V Blom, 1997, HLA expression in a primary uveal melanoma, its cell line, and four of its metastases, Br. J. Ophthalmol., 81, 989, 10.1136/bjo.81.11.989 Bodaghi, 1999, Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells, J. Immunol., 162, 957, 10.4049/jimmunol.162.2.957 Boonman, 2006, Macrophages are vital in spontaneous intraocular tumor eradication, Invest. Ophthalmol. Vis. Sci., 47, 2959, 10.1167/iovs.05-1427 Bora, 1993, Differential expression of the complement regulatory proteins in the human eye, Invest. Ophthalmol. Vis. Sci., 34, 3579 Bosch, 2007, MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells, Cancer Res., 67, 4499, 10.1158/0008-5472.CAN-06-3770 Brandacher, 2006, Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells, Clin. Cancer Res., 12, 1144, 10.1158/1078-0432.CCR-05-1966 Brocker, 1985, Phenotypic dynamics of tumor progression in human malignant melanoma, Int. J. Cancer, 36, 29, 10.1002/ijc.2910360106 Bronte, 2003, l-Arginine metabolism in myeloid cells controls T-lymphocyte functions, Trends Immunol., 24, 302, 10.1016/S1471-4906(03)00132-7 Bronte, 2005, Regulation of immune responses by l-arginine metabolism, Nat. Rev. Immunol., 5, 641, 10.1038/nri1668 Burnet, 1957, Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications, Br. Med. J., 1, 841, 10.1136/bmj.1.5023.841 Callaway, 1989, The incidence of late recurrence (greater than 10 years); an analysis of 536 consecutive cases of cutaneous melanoma, Br. J. Plast. Surg., 42, 46, 10.1016/S0007-1226(89)90111-2 Camelo, 2006, Antigen from the anterior chamber of the eye travels in a soluble form to secondary lymphoid organs via lymphatic and vascular routes, Invest. Ophthalmol. Vis. Sci., 47, 1039, 10.1167/iovs.05-1041 Camelo, 2004, The distribution of antigen in lymphoid tissues following its injection into the anterior chamber of the rat eye, J. Immunol., 172, 5388, 10.4049/jimmunol.172.9.5388 Carreno, 2002, The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses, Ann. Rev. Immunol., 20, 29, 10.1146/annurev.immunol.20.091101.091806 Char, 1978, Metastatic choroidal melanoma, Am. J. Ophthalmol., 86, 76, 10.1016/0002-9394(78)90018-1 Chen, 2007, Influence of immune surveillance and immune privilege on formation of intraocular tumors, Chem. Immunol. Allergy, 92, 276, 10.1159/000099278 Chen, 2007, Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion, Exp. Eye Res., 85, 617, 10.1016/j.exer.2007.07.014 Chen, 1997, Expression of MAGE genes in ocular melanoma cell lines, J. Immunother., 20, 265, 10.1097/00002371-199707000-00003 Coley, 1891, II. Contribution to the knowledge of sarcoma, Ann. Surg., 14, 199, 10.1097/00000658-189112000-00015 Coley, 1893, The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases, Am. J. Med. Sci., 105, 487, 10.1097/00000441-189305000-00001 COMS, 2001, Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS Report No. 15, Arch. Ophthalmol., 119, 670, 10.1001/archopht.119.5.670 Cousins, 1991, Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor, Invest. Ophthalmol. Vis. Sci., 32, 2201 Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 D'Orazio, 1999, Effect of aqueous humor on apoptosis of inflammatory cell types, Invest. Ophthalmol. Vis. Sci., 40, 1418 D'Orazio, 1998, The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response, Eur. J. Immunol., 28, 1544, 10.1002/(SICI)1521-4141(199805)28:05<1544::AID-IMMU1544>3.0.CO;2-P D'Orazio, 1998, A novel role for TGF-beta and IL-10 in the induction of immune privilege, J. Immunol., 160, 2089, 10.4049/jimmunol.160.5.2089 Dace, 2007, Ocular immune privilege is circumvented by CD4 + T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner, J. Leukoc. Biol., 81, 421, 10.1189/jlb.0806489 Dace, 2007, CD8 + T cells circumvent immune privilege in the eye and mediate intraocular tumor rejection by a TNF-a-dependent mechanism, J. Immunol, 178, 6115, 10.4049/jimmunol.178.10.6115 Dace, 2008, CD4 + T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages, Immunology, 123, 367, 10.1111/j.1365-2567.2007.02700.x Dannenberg, 2003, Targeting cyclooxygenase-2 in human neoplasia: rationale and promise, Cancer Cell, 4, 431, 10.1016/S1535-6108(03)00310-6 Daubener, 1999, IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism, Adv. Exp. Med. Biol., 467, 517, 10.1007/978-1-4615-4709-9_64 de la Cruz, 1990, Lymphocytic infiltration in uveal malignant melanoma, Cancer, 65, 112, 10.1002/1097-0142(19900101)65:1<112::AID-CNCR2820650123>3.0.CO;2-X de Waard-Siebinga, 1996, HLA expression and tumor-infiltrating immune cells in uveal melanoma, Graefes Arch. Clin. Exp. Ophthalmol., 234, 34, 10.1007/BF00186516 Della Chiesa, 2006, The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function, Blood, 108, 4118, 10.1182/blood-2006-03-006700 Demicheli, 1996, Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy, Breast Cancer Res. Treat, 41, 177, 10.1007/BF01807163 Ding, 2005, PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis, Clin. Immunol., 115, 184, 10.1016/j.clim.2005.01.005 Dithmar, 2000, Neoadjuvant interferon alfa-2b treatment in a murine model for metastatic ocular melanoma: a preliminary study, Arch. Ophthalmol., 118, 1085, 10.1001/archopht.118.8.1085 Dithmar, 1999, Depletion of NK cell activity results in growth of hepatic micrometastases in a murine ocular melanoma model, Curr. Eye Res., 19, 426, 10.1076/ceyr.19.5.426.5294 Dong, 2002, Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion, Nat. Med., 8, 793, 10.1038/nm0902-1039c Dong, 1999, B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion, Nat. Med., 5, 1365, 10.1038/70932 Dunn, 2002, Cancer immunoediting: from immunosurveillance to tumor escape, Nat. Immunol., 3, 991, 10.1038/ni1102-991 Dunn, 2006, Interferons, immunity and cancer immunoediting, Nat. Rev. Immunol., 6, 836, 10.1038/nri1961 Dunn, 2004, The immunobiology of cancer immunosurveillance and immunoediting, Immunity, 21, 137, 10.1016/j.immuni.2004.07.017 Dunn, 2004, The three Es of cancer immunoediting, Ann. Rev. Immunol., 22, 329, 10.1146/annurev.immunol.22.012703.104803 Durie, 1990, Analysis of lymphocytic infiltration in uveal melanoma, Invest. Ophthalmol. Vis. Sci., 31, 2106 Egan, 1996, Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site, J. Immunol., 157, 2262, 10.4049/jimmunol.157.6.2262 Ehrlich, 1909, Ueber den jetzigen Stand der Karzinomforschung, Ned Tijdschr Geneeskd, 5, 273 Ericsson, 2001, Association of HLA class I and class II antigen expression and mortality in uveal melanoma, Invest. Ophthalmol. Vis. Sci., 42, 2153 Esser, 2001, TGF-beta in uveal melanoma, Microsc. Res. Tech., 52, 396, 10.1002/1097-0029(20010215)52:4<396::AID-JEMT1024>3.0.CO;2-V Filer, 1993, Cytokines in uveal melanoma (Original title: uveal melanoma cytokines), Klin. Monatsbl. Augenheilkd, 202, 174, 10.1055/s-2008-1045579 Freeman, 2000, Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation, J. Exp. Med., 192, 1027, 10.1084/jem.192.7.1027 Frumento, 2002, Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase, J. Exp. Med., 196, 459, 10.1084/jem.20020121 Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat. Rev. Immunol., 9, 162, 10.1038/nri2506 Gombos, 2003, Therapy of uveal melanoma: methods and risk factors associated with treatment, 321 Goslings, 1996, Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas, Invest. Ophthalmol. Vis. Sci., 37, 1884 Goslings, 1998, A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation, Invest. Ophthalmol. Vis. Sci., 39, 989 Greene, 1958, A spontaneous melanoma in the hamster with a propensity for amelanotic alteration and sarcomatous transformation during transplantation, Cancer Res., 18, 422 Griffith, 1995, Fas ligand-induced apoptosis as a mechanism of immune privilege, Science, 270, 1189, 10.1126/science.270.5239.1189 Hainz, 2007, The role of indoleamine 2,3-dioxygenase in transplantation, Transpl. Int., 20, 118, 10.1111/j.1432-2277.2006.00370.x Hallermalm, 2004, Autocrine secretion of fas ligand shields tumor cells from fas-mediated killing by cytotoxic lymphocytes, Cancer Res., 64, 6775, 10.1158/0008-5472.CAN-04-0508 Hallermalm, 2008, Modulation of the tumor cell phenotype by IFN-gamma results in resistance of uveal melanoma cells to granule-mediated lysis by cytotoxic lymphocytes, J. Immunol., 180, 3766, 10.4049/jimmunol.180.6.3766 Hargrave, 2003, Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?, Transpl. Immunol., 11, 79, 10.1016/S0966-3274(02)00082-5 He, 2005, Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy, Cancer Immunol. Immunother., 54, 891, 10.1007/s00262-004-0654-1 He, 2004, Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells, Invest. Ophthalmol. Vis. Sci., 45, 4240, 10.1167/iovs.04-0599 Hegde, 2002, Effect of alloantibodies on corneal allograft survival, Invest. Ophthalmol. Vis. Sci., 43, 1012 Helbig, 1990, Dual effect of ciliary body cells on T lymphocyte proliferation, Eur. J. Immunol., 20, 2457, 10.1002/eji.1830201115 Herrlinger, 2005, Relapse of primary CNS lymphoma after more than 10 years in complete remission, J. Neurol., 252, 1409, 10.1007/s00415-005-0854-4 Hicklin, 1999, HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story, Mol. Med. Today, 5, 178, 10.1016/S1357-4310(99)01451-3 Holmes, 1992, Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55), Eur. J. Immunol., 22, 1579, 10.1002/eji.1830220635 Holmes, 1990, Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy, J. Immunol., 144, 3099, 10.4049/jimmunol.144.8.3099 Hooper, 1991, Inhibition of lymphocyte proliferation by resident ocular cells, Curr. Eye Res., 10, 363, 10.3109/02713689108996342 Hori, 2006, B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts, J. Immunol., 177, 5928, 10.4049/jimmunol.177.9.5928 Ino, 2006, Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer, Br. J. Cancer, 95, 1555, 10.1038/sj.bjc.6603477 Irving, 1991, The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways, Cell, 64, 891, 10.1016/0092-8674(91)90314-O Ishio, 2004, Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma, J. Gastroenterol. Hepatol., 19, 319, 10.1111/j.1440-1746.2003.03259.x Ishitani, 1992, Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens, Proc. Natl. Acad. Sci. USA, 89, 3947, 10.1073/pnas.89.9.3947 Jager, 2002, HLA expression in uveal melanoma: there is no rule without some exception, Hum. Immunol., 63, 444, 10.1016/S0198-8859(02)00389-0 Jager, 2002, HLA expressin in uveal melanoma: there is no rule without some exception, Hum. Immunol., 63, 444, 10.1016/S0198-8859(02)00389-0 Jampel, 1990, Transforming growth factor-beta in human aqueous humor, Curr. Eye Res., 9, 963, 10.3109/02713689009069932 Jensen, 1974, Spontaneous regression of malignant melanoma of the choroid, Acta Ophthalmol. (Copenh.), 52, 173, 10.1111/j.1755-3768.1974.tb00365.x Joly, 1991, Viral persistence in neurons explained by lack of major histocompatibility class I expression, Science, 253, 1283, 10.1126/science.1891717 Kan-Mitchell, 1991, Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients, Cancer Immunol. Immunother., 33, 333, 10.1007/BF01756599 Kaplan, 1998, Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice, Proc. Natl. Acad. Sci. USA, 95, 7556, 10.1073/pnas.95.13.7556 Kaplan, 1975, A reconsideration of immunological privilege within the anterior chamber of the eye, Transplantation, 19, 203, 10.1097/00007890-197504000-00005 Kaplan, 1977, Immune response to immunization via the anterior chamber of the eye. I.F. lymphocyte-induced immune deviation, J. Immunol., 118, 809, 10.4049/jimmunol.118.3.809 Kaplan, 1978, Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation, J. Immunol., 120, 689, 10.4049/jimmunol.120.3.689 Kaplan, 1975, Transplantation immunology of the anterior chamber of the eye. II. Immune response to allogeneic cells, J. Immunol., 115, 805, 10.4049/jimmunol.115.3.805 Kath, 1993, Prognosis and treatment of disseminated uveal melanoma [see comments], Cancer, 72, 2219, 10.1002/1097-0142(19931001)72:7<2219::AID-CNCR2820720725>3.0.CO;2-J Kelly, 1991, Enhancement of metastatic potential by gamma-interferon, Cancer Res., 51, 4020 Khodadoust, 1977, Spontaneous regression of retinoblastoma, Surv. Ophthalmol., 21, 467, 10.1016/S0039-6257(77)80003-9 Khong, 2002, Natural selection of tumor variants in the generation of “tumor escape” phenotypes, Nat. Immunol., 3, 999, 10.1038/ni1102-999 Klein, 1966, Tumor antigens, Ann. Rev. Microbiol., 20, 223, 10.1146/annurev.mi.20.100166.001255 Knisely, 1991, Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells, Curr. Eye Res., 10, 761, 10.3109/02713689109013870 Knisely, 1987, Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors, J. Immunol., 138, 4515, 10.4049/jimmunol.138.12.4515 Knisely, 1990, Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye, Cancer Immunol. Immunother., 30, 323, 10.1007/BF01786881 Kobayashi, 1985, Malignant neoplasms in registered cases of primary immunodeficiency syndrome, Jpn. J. Clin. Oncol., 15, 307 Kovats, 1990, A class I antigen, HLA-G, expressed in human trophoblasts, Science, 248, 220, 10.1126/science.2326636 Ksander, 1998, Uveal melanomas contain antigenically specific and non-specific infiltrating lymphocytes, Curr. Eye Res., 17, 165, 10.1076/ceyr.17.2.165.5607 Ksander, 1991, Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma, Invest. Ophthalmol. Vis. Sci., 32, 3198 Kusmartsev, 2004, Antigen-specific inhibition of CD8 + T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species, J. Immunol., 172, 989, 10.4049/jimmunol.172.2.989 Lai, 1996, Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma, Clin. Cancer Res., 2, 161 Lampson, 1984, Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon, Proc. Natl. Acad. Sci. USA, 81, 6476, 10.1073/pnas.81.20.6476 Lass, 1990, Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland, Invest. Ophthalmol. Vis. Sci., 31, 1136 Latchman, 2001, PD-L2 is a second ligand for PD-1 and inhibits T cell activation, Nat. Immunol., 2, 261, 10.1038/85330 Le Discorde, 2003, Expression of HLA-G in human cornea, an immune-privileged tissue, Hum. Immunol., 64, 1039, 10.1016/j.humimm.2003.08.346 Le Poole, 2002, Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells, Am. J. Pathol., 160, 521, 10.1016/S0002-9440(10)64871-7 LeBouteiller, 1994, HLA class I chromosomal region, genes, and products: facts and questions, Crit. Rev. Immunol., 14, 89, 10.1615/CritRevImmunol.v14.i2.10 Lee, 2002, TRAIL: a mechanism of tumor surveillance in an immune privileged site, J. Immunol., 169, 4739, 10.4049/jimmunol.169.9.4739 Lee, 1998, HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A, Proc. Natl. Acad. Sci. USA, 95, 5199, 10.1073/pnas.95.9.5199 Li, 2004, The induction of splenic suppressor T cells through an immune-privileged site requires an intact sympathetic nervous system, J. Neuroimmunol., 153, 40, 10.1016/j.jneuroim.2004.04.008 Li, 1997, Immune privilege in the anterior chamber of the eye is not extended to intraocular Listeria monocytogenes, Ocul. Immunol. Inflamm., 5, 245, 10.3109/09273949709085065 Liao, 1998, No requirement for V(D)J recombination in p53-deficient thymic lymphoma, Mol. Cell. Biol., 18, 3495, 10.1128/MCB.18.6.3495 Likhvantseva, 1999, [Interferon status of patients with uveal melanoma], Vestn. Oftalmol., 115, 35 Lin, 2004, Role of infiltrated leucocytes in tumour growth and spread, Br. J. Cancer, 90, 2053, 10.1038/sj.bjc.6601705 Ljunggren, 1990, In search of the ‘missing self’: MHC molecules and NK cell recognition, Immunol. Today, 11, 237, 10.1016/0167-5699(90)90097-S Luyten, 1998, Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines, Melanoma Res., 8, 11, 10.1097/00008390-199802000-00003 Ma, 1994, Rejection of intraocular tumors from transgenic mice by tumor-infiltrating lymphocytes, Curr. Eye Res., 13, 361, 10.3109/02713689409167300 Ma, 1994, Capacity of simian virus 40 T antigen to induce self-tolerance but not immunological privilege in the anterior chamber of the eye, Transplantation, 57, 718, 10.1097/00007890-199403150-00014 Ma, 1995, Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model, Invest. Ophthalmol. Vis. Sci., 36, 435 Ma, 1995, Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis, Immunology, 86, 263 Mahoney, 1990, The epidemiology of ophthalmic malignancies in New York State, Ophthalmology, 97, 1143, 10.1016/S0161-6420(90)32445-4 Makitie, 2001, Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma, Invest. Ophthalmol. Vis. Sci., 42, 1414 Malina, 1993, Indoleamine 2,3-dioxygenase activity in the aqueous humor, iris/ciliary body, and retina of the bovine eye, Graefes. Arch. Clin. Exp. Ophthalmol., 231, 482, 10.1007/BF02044236 Malina, 1996, Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye, Graefes. Arch. Clin. Exp. Ophthalmol., 234, 457, 10.1007/BF02539413 Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 Marincola, 2000, Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance, Adv. Immunol., 74, 181, 10.1016/S0065-2776(08)60911-6 Matsui, 2006, Relapse of stage I small cell lung cancer ten or more years after the start of treatment, Jpn. J. Clin. Oncol., 36, 457, 10.1093/jjco/hyl044 McCarthy, 1993, Conjunctival and uveal melanoma in the dysplastic nevus syndrome, Surv. Ophthalmol., 37, 377, 10.1016/0039-6257(93)90068-I McKenna, K.C., Beatty, K.M., et al., in press. Activated CD11b+ CD15+ granulocytes increase in blood of uveal melanoma patients. Invest. Ophthalmol. Vis. Sci. McKenna, 2006, Accumulation of immunosuppressive CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the anterior chamber of the eye, J. Immunol., 177, 1599, 10.4049/jimmunol.177.3.1599 Medawar, 1948, Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye, Br. J. Exp. Pathol., 29, 58 Meecham, 1992, Infiltrating lymphocytes and antigen expression in uveal melanoma, Ophthal. Res., 24, 20, 10.1159/000267140 Mellor, 2002, Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses, J. Immunol., 168, 3771, 10.4049/jimmunol.168.8.3771 Meng, 2004, Circulating tumor cells in patients with breast cancer dormancy, Clin. Cancer Res., 10, 8152, 10.1158/1078-0432.CCR-04-1110 Mizuno, 1989, Histopathologic analysis of experimental autoimmune uveitis attenuated by intracameral injection of S-antigen, Curr. Eye Res., 8, 113, 10.3109/02713688909013900 Mizuno, 1988, Induction of anterior chamber associated immune deviation in rats receiving intracameral injections of retinal S antigen, Curr. Eye Res., 7, 627, 10.3109/02713688809031820 Mulcahy, 1996, Infrequent expression of the MAGE gene family in uveal melanomas, Int. J. Cancer, 66, 738, 10.1002/(SICI)1097-0215(19960611)66:6<738::AID-IJC5>3.0.CO;2-0 Munn, 1999, Inhibition of T cell proliferation by macrophage tryptophan catabolism, J. Exp. Med., 189, 1363, 10.1084/jem.189.9.1363 Munn, 1998, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science, 281, 1191, 10.1126/science.281.5380.1191 Nacht, 1998, V(D)J recombination is not required for the development of lymphoma in p53-deficient mice, Cell Growth Differ, 9, 131 Namba, 2002, Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2, J. Leukoc. Biol., 72, 946, 10.1189/jlb.72.5.946 Natali, 1989, Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies, Cancer Res., 49, 1269 Niederkorn, 1981, Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice, Invest. Ophthalmol. Vis. Sci., 20, 355 Niederkorn, 1991, The immunopathology of intraocular tumour rejection, Eye, 5, 186, 10.1038/eye.1991.33 Niederkorn, 1995, Immunopathogenesis of intraocular tumors, Prog. Ret. Eye Res., 14, 505, 10.1016/1350-9462(94)00017-A Niederkorn, 1997, Immunoregulation of intraocular tumours, Eye, 11, 249, 10.1038/eye.1997.60 Niederkorn, 2002, Natural killer cells and uveal melanoma, 73 Niederkorn, 2006, Anterior chamber-associated immune deviation and its impact on corneal allograft survival, Curr. Opin. Organ Transplant., 11, 360, 10.1097/01.mot.0000236697.07092.ac Niederkorn, 2006, See no evil, hear no evil, do no evil: the lessons of immune privilege, Nat. Immunol., 7, 354, 10.1038/ni1328 Niederkorn, 2007, The induction of anterior chamber-associated immune deviation, Chem. Immunol. Allergy, 92, 27, 10.1159/000099251 Niederkorn, 1999, Expression of a nonclassical MHC class Ib molecule in the eye, Transplantation, 68, 1790, 10.1097/00007890-199912150-00025 Niederkorn, 1988, Immunological analysis of a destructive pattern of intraocular tumor resolution, Curr. Eye Res., 7, 515, 10.3109/02713688809031806 Niederkorn, 1996, Anterior chamber-associated immune deviation promotes corneal allograft survival, Invest. Ophthalmol. Vis. Sci., 37, 2700 Niederkorn, 1985, Spontaneous immune rejection of intraocular tumors in mice, Invest. Ophthalmol. Vis. Sci., 26, 877 Niederkorn, 2005, Immunology of intraocular tumors, Ocul. Immunol. Inflamm., 13, 105, 10.1080/09273940490518586 Nishida, 1999, Specific aqueous humor factors induce activation of regulatory T cells, Invest. Ophthalmol. Vis. Sci., 40, 2268 Nishimura, 2001, PD-1: an inhibitory immunoreceptor involved in peripheral tolerance, Trends Immunol., 22, 265, 10.1016/S1471-4906(01)01888-9 Nitta, 1990, Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma, Science, 249, 672, 10.1126/science.2382141 Okazaki, 2007, PD-1 and PD-1 ligands: from discovery to clinical application, Int. Immunol., 19, 813, 10.1093/intimm/dxm057 Old, 1966, Specific antigens of tumors and leukemias of experimental animals, Med. Clin. North Am., 50, 901, 10.1016/S0025-7125(16)33187-X Ostrand-Rosenberg, 2009, Myeloid-derived suppressor cells: linking inflammation and cancer, J. Immunol., 182, 4499, 10.4049/jimmunol.0802740 Penn, 1996, Malignant melanoma in organ allograft recipients, Transplantation, 61, 274, 10.1097/00007890-199601270-00019 Prehn, 1972, The immune reaction as a stimulator of tumor growth, Science, 176, 170, 10.1126/science.176.4031.170 Prehn, 1971, An immunostimulation theory of tumor development, Transplant. Rev., 7, 26 Raja, 2003, Cytotoxic granule-mediated apoptosis: unraveling the complex mechanism, Curr. Opin. Immunol., 15, 528, 10.1016/S0952-7915(03)00111-0 Reese, 1966, Precancerous and cancerous melanosis, Am. J. Ophthalmol., 61, 1272, 10.1016/0002-9394(66)90256-X Reiman, 2007, Tumor immunoediting and immunosculpting pathways to cancer progression, Semin. Cancer Biol., 17, 275, 10.1016/j.semcancer.2007.06.009 Repp, 2000, Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells, J. Immunol., 165, 710, 10.4049/jimmunol.165.2.710 Roberts, 2007, Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis, Proc. Natl. Acad. Sci. USA, 104, 6770, 10.1073/pnas.0604982104 Rook, 1986, Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness, J. Immunol., 136, 3916, 10.4049/jimmunol.136.10.3916 Rooney, 1993, Complement in human reproduction: activation and control, Immunol. Res., 12, 276, 10.1007/BF02918258 Rouas-Freiss, 1997, Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis, Proc. Natl. Acad. Sci. USA, 94, 11520, 10.1073/pnas.94.21.11520 Ruiter, 1984, Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens, Cancer Res., 44, 3930 Ruiter, 1982, Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma, J. Immunol., 129, 2808, 10.4049/jimmunol.129.6.2808 Ruiter, 1991, MHC antigens in human melanomas, Semin. Cancer Biol., 2, 35 Russell, 1979, Characteristics of a retrovirus associated with a hamster melanoma, J. Gen. Virol., 43, 317, 10.1099/0022-1317-43-2-317 Ryu, 2007, Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor, Invest. Ophthalmol. Vis. Sci., 48, 4148, 10.1167/iovs.05-1336 Sagalowsky, 1999, Solitary metastasis of renal cell carcinoma to the contralateral adrenal gland 22 years after nephrectomy, Urology, 54, 162, 10.1016/S0090-4295(98)00661-X Saunders, 2005, PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion, Eur. J. Immunol., 35, 3561, 10.1002/eji.200526347 Schneider, 1998, Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity, J. Exp. Med., 187, 1205, 10.1084/jem.187.8.1205 Schurmans, 1999, Successful immunotherapy of an intraocular tumor in mice, Cancer Res., 59, 5250 Schurmans, 2001, Rejection of intraocular tumors by CD4(+) T cells without induction of phthisis, J. Immunol., 167, 5832, 10.4049/jimmunol.167.10.5832 Shacter, 2002, Chronic inflammation and cancer, Oncology (Williston Park), 16, 217 Shankaran, 2001, IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, 410, 1107, 10.1038/35074122 She, 1990, Intracameral injection of allogeneic lymphocytes enhances corneal graft survival, Invest. Ophthalmol. Vis. Sci., 31, 1950 Shen, 2007, The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival, J. Immunol., 179, 3672, 10.4049/jimmunol.179.6.3672 Sherman, 1978, The fate of anterior chamber flurescein in the monkey eye. 1. The anterior chamber outflow pathways, Exp. Eye Res., 27, 159, 10.1016/0014-4835(78)90086-6 Singh, 2003, Survival rates with uveal melanoma in the United States: 1973–1997, Ophthalmology, 110, 962, 10.1016/S0161-6420(03)00077-0 Smyth, 2006, Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity, Adv. Immunol., 90, 1, 10.1016/S0065-2776(06)90001-7 Smyth, 2000, Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma, J. Exp. Med., 192, 755, 10.1084/jem.192.5.755 Sohn, 2000, Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins, Invest. Ophthalmol. Vis. Sci., 41, 3492 Sohn, 2000, Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59, Invest. Ophthalmol. Vis. Sci., 41, 4195 Sonoda, 2002, Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells, J. Immunol., 168, 2028, 10.4049/jimmunol.168.4.2028 Sonoda, 1993, Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts, J. Immunol., 150, 1727, 10.4049/jimmunol.150.5.1727 Staibano, 2006, Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?, Int. J. Immunopathol. Pharmacol., 19, 171, 10.1177/205873920601900117 Streilein, 2003, Ocular immune privilege: therapeutic opportunities from an experiment of nature, Nat. Rev. Immunol., 3, 879, 10.1038/nri1224 Streilein, 1981, Induction of anterior chamber-associated immune deviation requires an intact, functional spleen, J. Exp. Med., 153, 1058, 10.1084/jem.153.5.1058 Stuart, 1997, CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival, J. Clin. Invest., 99, 396, 10.1172/JCI119173 Stutman, 1974, Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice, Science, 183, 534, 10.1126/science.183.4124.534 Stutman, 1975, Immunodepression and malignancy, Adv. Cancer Res., 22, 261, 10.1016/S0065-230X(08)60179-7 Sugita, 2009, Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1 + T helper 1 cells by a contact-dependent mechanism, Invest. Ophthalmol. Vis. Sci., 50, 263, 10.1167/iovs.08-2536 Swann, 2007, Immune surveillance of tumors, J. Clin. Invest., 117, 1137, 10.1172/JCI31405 Takikawa, 1991, Induction of indoleamine 2,3-dioxygenase in tumor cells transplanted into allogeneic mouse: interferon-gamma is the inducer, Adv. Exp. Med. Biol., 294, 437, 10.1007/978-1-4684-5952-4_40 Takikawa, 1999, Regulation of indoleamine 2,3-dioxygenase, the first enzyme in UV filter biosynthesis in the human lens. Relevance for senile nuclear cataract, Adv. Exp. Med. Biol., 467, 241, 10.1007/978-1-4615-4709-9_31 Taniguchi, 1987, Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens, Proc. Natl. Acad. Sci. USA, 84, 3405, 10.1073/pnas.84.10.3405 Taylor, 2001, In vitro induction of CD25 + CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH), Immunol. Cell. Biol., 79, 358, 10.1046/j.1440-1711.2001.01022.x Taylor, 2007, Ocular immunosuppressive microenvironment, Chem. Immunol., 92, 71, 10.1159/000099255 Taylor, 2003, Somatostatin is an immunosuppressive factor in aqueous humor, Invest. Ophthalmol. Vis. Sci., 44, 2644, 10.1167/iovs.02-1216 Teng, 2008, Immune-mediated dormancy: an equilibrium with cancer, J. Leukoc. Biol., 84, 988, 10.1189/jlb.1107774 Terness, 2002, Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites, J. Exp. Med., 196, 447, 10.1084/jem.20020052 Thomas, 1959, Reactions to homologous tissue antigens in relation to hypersensitivity, 529 Uyttenhove, 2003, Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase, Nat. Med., 9, 1269, 10.1038/nm934 van Dooremaal, 1873, Die Entwicklung der in fremden Grund versetzten lebenden Geweba, Albrecht von Graefes Arch. Ophthalmol., 19, 358 van Duinen, 1988, Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma, Cancer Res., 48, 1019 Verbik, 1997, Melanomas that develop within the eye inhibit lymphocyte proliferation, Int. J. Cancer, 73, 470, 10.1002/(SICI)1097-0215(19971114)73:4<470::AID-IJC3>3.0.CO;2-X Vetter, 2004, Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma, Br. J. Cancer, 91, 1495, 10.1038/sj.bjc.6602123 Vijayasaradhi, 1995, Melanoma and melanocytes: pigmentation, tumor progression, and the immune response to cancer, Adv. Pharmacol., 32, 343, 10.1016/S1054-3589(08)61017-0 Wang, 2003, Role of TRAIL and IFN-gamma in CD4 + T cell-dependent tumor rejection in the anterior chamber of the eye, J. Immunol., 171, 2789, 10.4049/jimmunol.171.6.2789 Wang, 2001, Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation, J. Leukoc. Biol., 69, 741, 10.1189/jlb.69.5.741 Weinlich, 2007, Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients, Dermatology, 214, 8, 10.1159/000096906 Whittum, 1982, Intracameral inoculation of herpes simplex virus type I induces anterior chamber-associated immune deviation, Curr. Eye Res., 2, 691, 10.3109/02713688209019998 Wilbanks, 1992, Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta, Eur. J. Immunol., 22, 165, 10.1002/eji.1830220125 Wilbanks, 1991, Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood, J. Immunol., 146, 2610, 10.4049/jimmunol.146.8.2610 Wilbanks, 1992, Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta, Eur. J. Immunol., 22, 1031, 10.1002/eji.1830220423 Xu, 2000, A critical role for murine complement regulator crry in fetomaternal tolerance, Science, 287, 498, 10.1126/science.287.5452.498 Yamagami, 1997, Role of Fas–Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants, Transplantation, 64, 1107, 10.1097/00007890-199710270-00004 Yang, 2008, PD–L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro, Invest. Ophthalmol. Vis. Sci., 49, 2518, 10.1167/iovs.07-1606 Yang, 2009, PD-L1 expression on human ocular cells and its possible role in regulating immune-mediated ocular inflammation, Invest. Ophthalmol. Vis. Sci., 50, 273, 10.1167/iovs.08-2397 Yoshida, 2000, Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells, Invest. Ophthalmol. Vis. Sci., 41, 3862 Yoshida, 2000, Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact, Invest. Ophthalmol. Vis. Sci., 41, 811 Zamiri, 2005, Thrombospondin plays a vital role in the immune privilege of the eye, Invest. Ophthalmol. Vis. Sci., 46, 908, 10.1167/iovs.04-0362 Zea, 2004, l-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes, Cell. Immunol., 232, 21, 10.1016/j.cellimm.2005.01.004 Zeiss, 2003, Feline intraocular tumors may arise from transformation of lens epithelium, Vet. Pathol., 40, 355, 10.1354/vp.40-4-355 Zirm, 1906, Eine erfolgreiche totale Keratoplastik, Albrecht von Graefes. Arch. Ophthalmol., 64, 580, 10.1007/BF01949227